The University of Southampton
University of Southampton Institutional Repository

The impact of Pediatric Outpatient Parenteral Antibiotic Therapy (p-OPAT) implementation at a tertiary children's hospital in the United Kingdom

The impact of Pediatric Outpatient Parenteral Antibiotic Therapy (p-OPAT) implementation at a tertiary children's hospital in the United Kingdom
The impact of Pediatric Outpatient Parenteral Antibiotic Therapy (p-OPAT) implementation at a tertiary children's hospital in the United Kingdom
Background: Recent advances in outpatient parenteral antibiotic therapy (OPAT) have largely focused on adult practice, and there are few published data on the safety and effectiveness of pediatric OPAT (p-OPAT).

Methods: During a 3-year period (2012 to 2015), data were prospectively collected on patients managed within the p-OPAT service at Southampton Children’s Hospital, a tertiary pediatric hospital in the South of England.

Results: A total of 130 p-OPAT episodes were managed during this period. The most frequently managed pathologies were bone and joint infections (44.6%), followed by ear, nose and throat (10.7%), respiratory (10.0%) and central nervous system (10.0%) infections. The most frequently used antimicrobial agent was ceftriaxone (n = 103; 79.2%). For the majority of p-OPAT episodes, antimicrobials were delivered in prefilled syringes (n = 109; 83.8%); 24-hour infusions administered by elastomeric devices were used less commonly (n = 16; 12.3%). The median duration of p-OPAT treatment was 9.2 days (interquartile range: 7.6–19.0 days). With regard to patient outcomes, 113 (86.9%) p-OPAT episodes resulted in cure and 12 (9.2%) in improvement; treatment failure occurred in 5 (3.9%) episodes. Intravenous catheter–related complications were rare. A total of 1683 bed days were saved over the 3-year period.

Conclusions: Our data suggest that p-OPAT is safe and effective, with the potential to offer considerable savings for the healthcare economy through reduced length of inpatient stay.
2048-7193
e292-e297
Patel, Sanjay
bc976df6-0414-459f-8390-3eca85e07d97
Burzio, Valentina
08613f96-f295-46b6-9290-ebf2d85db9b5
Green, Helen
9a446138-c1b3-4548-969a-19c96e98905f
Rees, Sara
fed1b1a6-6d68-4069-b086-017f0f94a002
Tebruegge, Marc
2c3dff22-0b5f-48a7-bb36-ce323705f74a
Jones, Christine E.
48229079-8b58-4dcb-8374-d9481fe7b426
Faust, Saul N.
f97df780-9f9b-418e-b349-7adf63e150c1
Patel, Sanjay
bc976df6-0414-459f-8390-3eca85e07d97
Burzio, Valentina
08613f96-f295-46b6-9290-ebf2d85db9b5
Green, Helen
9a446138-c1b3-4548-969a-19c96e98905f
Rees, Sara
fed1b1a6-6d68-4069-b086-017f0f94a002
Tebruegge, Marc
2c3dff22-0b5f-48a7-bb36-ce323705f74a
Jones, Christine E.
48229079-8b58-4dcb-8374-d9481fe7b426
Faust, Saul N.
f97df780-9f9b-418e-b349-7adf63e150c1

Patel, Sanjay, Burzio, Valentina, Green, Helen, Rees, Sara, Tebruegge, Marc, Jones, Christine E. and Faust, Saul N. (2018) The impact of Pediatric Outpatient Parenteral Antibiotic Therapy (p-OPAT) implementation at a tertiary children's hospital in the United Kingdom. Journal of the Pediatric Infectectious Diseases Society, 37 (12), e292-e297. (doi:10.1097/INF.0000000000002031).

Record type: Article

Abstract

Background: Recent advances in outpatient parenteral antibiotic therapy (OPAT) have largely focused on adult practice, and there are few published data on the safety and effectiveness of pediatric OPAT (p-OPAT).

Methods: During a 3-year period (2012 to 2015), data were prospectively collected on patients managed within the p-OPAT service at Southampton Children’s Hospital, a tertiary pediatric hospital in the South of England.

Results: A total of 130 p-OPAT episodes were managed during this period. The most frequently managed pathologies were bone and joint infections (44.6%), followed by ear, nose and throat (10.7%), respiratory (10.0%) and central nervous system (10.0%) infections. The most frequently used antimicrobial agent was ceftriaxone (n = 103; 79.2%). For the majority of p-OPAT episodes, antimicrobials were delivered in prefilled syringes (n = 109; 83.8%); 24-hour infusions administered by elastomeric devices were used less commonly (n = 16; 12.3%). The median duration of p-OPAT treatment was 9.2 days (interquartile range: 7.6–19.0 days). With regard to patient outcomes, 113 (86.9%) p-OPAT episodes resulted in cure and 12 (9.2%) in improvement; treatment failure occurred in 5 (3.9%) episodes. Intravenous catheter–related complications were rare. A total of 1683 bed days were saved over the 3-year period.

Conclusions: Our data suggest that p-OPAT is safe and effective, with the potential to offer considerable savings for the healthcare economy through reduced length of inpatient stay.

Text
P-OPAT paper - FINAL 4_12_17 - Accepted Manuscript
Download (147kB)

More information

Accepted/In Press date: 28 February 2018
Published date: 1 December 2018

Identifiers

Local EPrints ID: 418844
URI: http://eprints.soton.ac.uk/id/eprint/418844
ISSN: 2048-7193
PURE UUID: 30f47c8b-e7c7-4aca-adfe-86c69e59156e
ORCID for Christine E. Jones: ORCID iD orcid.org/0000-0003-1523-2368
ORCID for Saul N. Faust: ORCID iD orcid.org/0000-0003-3410-7642

Catalogue record

Date deposited: 23 Mar 2018 17:30
Last modified: 16 Mar 2024 06:23

Export record

Altmetrics

Contributors

Author: Sanjay Patel
Author: Valentina Burzio
Author: Helen Green
Author: Sara Rees
Author: Marc Tebruegge
Author: Saul N. Faust ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×